Quantinno Capital Management LP increased its holdings in Aflac Incorporated (NYSE:AFL – Free Report) by 3.5% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 152,801 shares of the financial services provider’s stock after purchasing an additional 5,178 shares during the period. Quantinno Capital Management LP’s holdings in Aflac were worth $17,083,000 as of its most recent SEC filing.
Other institutional investors also recently made changes to their positions in the company. Spinnaker Trust increased its stake in Aflac by 2.7% during the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock valued at $405,000 after purchasing an additional 95 shares in the last quarter. Secure Asset Management LLC increased its stake in Aflac by 1.0% during the 3rd quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider’s stock valued at $1,094,000 after purchasing an additional 96 shares in the last quarter. Ascent Group LLC increased its stake in Aflac by 0.6% during the 2nd quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider’s stock valued at $1,539,000 after purchasing an additional 99 shares in the last quarter. Ieq Capital LLC increased its stake in Aflac by 0.5% during the 2nd quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider’s stock valued at $1,945,000 after purchasing an additional 101 shares in the last quarter. Finally, New Century Financial Group LLC increased its stake in Aflac by 2.5% during the 3rd quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock valued at $469,000 after purchasing an additional 101 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.
Aflac Stock Performance
AFL opened at $106.99 on Thursday. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.32. The company has a market cap of $59.44 billion, a price-to-earnings ratio of 16.11, a PEG ratio of 2.13 and a beta of 0.97. The company’s 50 day moving average is $111.16 and its 200 day moving average is $101.97. Aflac Incorporated has a 12-month low of $75.07 and a 12-month high of $115.50.
Aflac Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.17%. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s payout ratio is currently 34.94%.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on AFL shares. Evercore ISI reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday. Barclays began coverage on shares of Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target on the stock. JPMorgan Chase & Co. raised their price target on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. Piper Sandler raised their price target on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Finally, Morgan Stanley raised their price target on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $98.73.
Check Out Our Latest Report on AFL
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- Quiet Period Expirations Explained
- Tesla Poised to Hit Record Highs This Holiday Season
- CD Calculator: Certificate of Deposit Calculator
- The Salesforce Rally is Just Getting Started: Here’s Why
- What Are Earnings Reports?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.